home / stock / casi / casi quote
Last: | $2.44 |
---|---|
Change Percent: | 0.0% |
Open: | $2.51 |
Close: | $2.44 |
High: | $2.58 |
Low: | $2.44 |
Volume: | 9,117 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.44 | $2.51 | $2.44 | $2.58 | $2.44 | 9,117 | 04-24-2024 |
$2.51 | $2.4113 | $2.51 | $2.51 | $2.3601 | 12,017 | 04-23-2024 |
$2.43 | $2.33 | $2.43 | $2.5 | $2.28 | 13,103 | 04-22-2024 |
$2.25 | $2.18 | $2.25 | $2.3 | $2.18 | 10,089 | 04-19-2024 |
$2.24 | $2.28 | $2.24 | $2.36 | $2.14 | 91,870 | 04-18-2024 |
$2.24 | $2.25 | $2.24 | $2.35 | $2.05 | 41,073 | 04-17-2024 |
$2.34 | $2.3 | $2.34 | $2.4099 | $2.0901 | 30,260 | 04-16-2024 |
$2.5 | $2.58 | $2.5 | $2.58 | $2.47 | 10,607 | 04-15-2024 |
$2.6 | $2.6 | $2.6 | $2.68 | $2.5 | 33,509 | 04-12-2024 |
$2.65 | $2.96 | $2.65 | $2.96 | $2.61 | 89,141 | 04-11-2024 |
$2.96 | $3.13 | $2.96 | $3.13 | $2.95 | 100,059 | 04-10-2024 |
$3.13 | $3.07 | $3.13 | $3.26 | $3.04 | 12,806 | 04-09-2024 |
$3.11 | $3.23 | $3.11 | $3.245 | $3.03 | 11,216 | 04-08-2024 |
$3.2 | $3.31 | $3.2 | $3.35 | $3.1 | 52,423 | 04-05-2024 |
$3.31 | $3.35 | $3.31 | $3.45 | $3.21 | 20,845 | 04-04-2024 |
$3.27 | $3.49 | $3.27 | $3.49 | $3.18 | 129,147 | 04-03-2024 |
$3.51 | $3.65 | $3.51 | $3.65 | $3.42 | 9,394 | 04-02-2024 |
$3.66 | $3.69 | $3.66 | $3.69 | $3.44 | 97,022 | 04-01-2024 |
$3.61 | $2.95 | $3.61 | $3.72 | $2.95 | 127,150 | 03-29-2024 |
$3.61 | $2.95 | $3.61 | $3.72 | $2.95 | 127,150 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing a...